Keratin Discovery Opens Door to New Skin Disease Treatments

A protein that helps form our skin, hair, and nails might hold the key to treating painful inflammatory skin conditions that affect millions of people worldwide.

Researchers at the University of Michigan discovered that keratin 16 acts as a natural brake on inflammation in our skin. When this protein is mutated or missing, the brake fails, leading to conditions like psoriasis, eczema, and a rare disorder called pachyonychia congenita (PC).

The team focused on PC, a genetic disorder that causes keratin 16 mutations. People with PC develop painful calluses and blisters on high-friction areas like their feet, making simple activities like walking excruciating. The disorder disrupts the network of filaments that help skin cells resist mechanical stress.

But the discovery goes far beyond one rare condition. The researchers found that keratin 16 controls type I interferons, a family of proteins that orchestrate immune responses. When keratin 16 is working properly, it keeps these interferons in check, preventing excessive inflammation.

"Knowing that Keratin 16 acts as an inflammatory brake gives us a direct target for new treatments and diagnostics," said lead researchers Erez Cohen and Pierre Coulombe in a joint statement.

The team studied skin samples from PC patients and lab mice with similar conditions. They also disabled the keratin 16 gene in another group of mice to see what happened without it. In both cases, inflammation skyrocketed when keratin 16 was mutated or missing.

The findings flip traditional understanding on its head. "Keratins are like the steel cables or steel beams of the cell," explained Wendy Bollag, a professor at Augusta University who wasn't involved with the study. Scientists have long known keratin provides structural support, but this immune-regulating function represents entirely new territory.

Why This Inspires

This discovery matters because it transforms how scientists view the skin's defense system. Instead of seeing keratin as just structural scaffolding, researchers now understand it plays an active role in controlling inflammation.

The implications reach millions. People with psoriasis and eczema could benefit from treatments targeting this newly understood mechanism. Even those without diagnosed conditions could see better options for managing skin inflammation.

The research team used multiple techniques to verify their findings, making the results particularly compelling. Published in Science Translational Medicine, the study opens doors to therapies that could specifically target the keratin 16 pathway, offering hope without the side effects of broader anti-inflammatory drugs.

Scientists are already exploring how to harness this discovery for new diagnostics and treatments, potentially transforming care for inflammatory skin diseases.